Nonsteroidal anti-inflammatory drugs: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "* " to "*") |
(→Types) |
||
| Line 20: | Line 20: | ||
===Selective COX-2 inhibitors (Coxibs)=== | ===Selective COX-2 inhibitors (Coxibs)=== | ||
*[[Celecoxib]] (FDA alert<ref>Information for Healthcare Professionals: Celecoxib (marketed as Celebrex) http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124655.htm</ref>) | *[[Celecoxib]] (FDA alert<ref>Information for Healthcare Professionals: Celecoxib (marketed as Celebrex) http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124655.htm</ref>) | ||
===Enolic acid (Oxicam) derivatives=== | |||
*Piroxicam | |||
*[[Meloxicam]] | |||
*Tenoxicam | |||
*Droxicam | |||
==See Also== | ==See Also== | ||
Revision as of 20:40, 26 September 2016
Background
- Abbreviation: NSAIDs
Types
Salicylates
- Aspirin (acetylsalicylic acid)
- Salicylic acid and other salicylates
Propionic acid derivatives
Acetic acid derivatives
Selective COX-2 inhibitors (Coxibs)
Enolic acid (Oxicam) derivatives
- Piroxicam
- Meloxicam
- Tenoxicam
- Droxicam
See Also
References
- ↑ Information for Healthcare Professionals: Celecoxib (marketed as Celebrex) http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124655.htm